Morgan Stanley’s Ambit Biosciences Corp AMBI Stock Holding History

Morgan Stanley’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-88,336	Closed	-$1.36M	–	6916
2014 Q3	$1.36M	Buy	88,336 +70,397	+392%	+$484K	﹤0.01%	3768
2014 Q2	$124K	Sell	17,939 -107,048	-86%	-$751K	﹤0.01%	5398
2014 Q1	$1.14M	Buy	124,987 +42,646	+52%	+$453K	﹤0.01%	3879
2013 Q4	$794K	Buy	82,341 +50,236	+156%	+$671K	﹤0.01%	4107
2013 Q3	$498K	Buy	32,105 +7,271	+29%	+$96.4K	﹤0.01%	4337
2013 Q2	$174K	Buy	+24,834	New	+$178K	﹤0.01%	4904

Morgan Stanley's AMBI Position: Q4 2014 in Review

Morgan Stanley sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 88,336 shares — an estimated $1.36M sold.

Morgan Stanley first reported a position in AMBI in Q2 2013 and held it in 6 quarters. The position peaked at $1.36M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Morgan Stanley reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Morgan Stanley sold 88,336 Ambit Biosciences Corp shares in Q4 2014, an estimated $1.36M.
Morgan Stanley first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 6 quarters.
Morgan Stanley's Ambit Biosciences Corp position peaked at $1.36M in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Morgan Stanley's 13F filing for Q4 2014, filed 13 Feb 2015.